← All organizations
Besins Healthcare
For profitWebsite ↗
Also known as: Ascend Therapeutics | ASCEND Therapeutics | Besins Healthcare | Besins Healthcare (funding: investigator-initiated and independent grant) | BESINS HLTHCARE | Besins Laboratory, Belgium | Besins Pharma GmbH | BHR Pharma, LLC | Dr. Kade/Besins Pharma GmbH, Rigistr. 2, 12277 Berlin | Laboratoires Besins International
Highest phase reached
Phase 4
Timeline
1880s
- Jun 1, 1885
Besins Healthcare— Founded
2000s
- Feb 28, 2000
testosterone— Marketing Organization
- Feb 28, 2000
testosterone— NDA Secondary Org
Drugs by trial phase (8 distinct, 18 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Atrophy
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Carcinoma In Situ
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal, Breast
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Colorectal Neoplasms
- Gonadal Disorders
- Hypogonadism
- Lymphoma
- Mastodynia
- Obstetric Labor, Premature
- Perinatal Death
- Premature Birth
- Prostatic Neoplasms
- Wounds and Injuries
Marketed drugs (1)
Recent trials (22)
- NCT04833426CollaboratorPhase 3Sep 1, 2021
- NCT04853069CollaboratorPhase 2May 17, 2021
- NCT04492553CollaboratorPhase 2Jan 31, 2021
- NCT03199963Lead sponsorPhase 3Aug 21, 2017
- NCT03199963Study directorPhase 3Aug 21, 2017
- NCT03202186Lead sponsorPhase 3Jul 1, 2017
- NCT02993159Lead sponsorPhase 2Jun 1, 2017
- NCT03063619Lead sponsorPhase 2May 30, 2017
- NCT02419105CollaboratorPhase 3Sep 1, 2015
- NCT02349386Study directorPhase 2Jul 1, 2015
- NCT02349386Lead sponsorPhase 2Jul 1, 2015
- NCT01786473Lead sponsorPhase 3Dec 1, 2012
- NCT01143064Study directorPhase 3Jun 1, 2010
- NCT01143064Lead sponsorPhase 3Jun 1, 2010
- NCT00598247CollaboratorPhase 1Jan 1, 2008
Details
- Founded
- Paris, FR Jun 1, 1885
- Last known activity
- Sep 1, 2021